This is a diagnostic kit for early diagnosis of patients with Lyme disease which is able to detect the disease with higher efficacy than currently used tests. It also allows to diagnose the patient more quickly after tick infestation, especially when the patient is infected with rarer Borrelia pathogens. Although Lyme disease is among the most intensively studied tick-borne diseases, there is no vaccine available for this disease so far. Current tests use markers of later stages of the disease, have an efficacy of about 70%, and are unable to detect the early stages. Lyme borreliosis does not cause death directly, but if the diagnosis is late, the spirochetes are able to settle in the body, for example, in joint fluid, and cause life-threatening health problems in patients, and there is a risk of relapse if the immune system is weakened. This test is ultimately able to save the costs of treating patients, as timely and accurate diagnostics will allow shorter treatment and reduce relapses and chronic disease states.
